Miraculous Recovery of Hypoxemic COVID-19 Patients With Ivermectin

Unhooking spike hemagglutinated red blood cells

A health worker shows a bottle of Ivermectin as part of a study of the Center for Paediatric Infectious Diseases Studies, in Cali, Colombia, on July 21, 2020. Luis Robayo/AFP via Getty Images

The past three years have generated millions of case vignettes of patients with COVID-19 respiratory illness. The most dramatic cases include critically ill inpatients with severe hypoxemia despite maximum respiratory support.

Reposted from the author’s Substack

---

[i] SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects Celine Boschi, David E. Scheim, Audrey Bancod, Muriel Millitello, Marion Le Bideau, Philippe Colson, Jacques Fantini, Bernard La Scola bioRxiv 2022.11.24.517882; doi: https://doi.org/10.1101/2022.11.24.517882

[ii] Stone, J.C.; Ndarukwa, P.; Scheim, D.E.; Dancis, B.M.; Dancis, J.; Gill, M.G.; Aldous, C. Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62% Normalization within 24 Hours. Biologics 2022, 2, 196-210. https://doi.org/10.3390/biologics2030015

[iii] This well constructed case demonstrates recovery from COVID-19 respiratory illness and advanced hypoxemia with inpatient ivermectin.